Clinical Trial Update: Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A completed Phase II study evaluating a combined modality treatment for primary testicular non-Hodgkin lymphoma (B-cell lymphoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: International Extranodal Lymphoma Study Group (IELSG) | Conditions: Lymphoma, B Cell | Phase 2 | Status: COMPLETED